EP0912170A4 - Inhibiteurs de la protease du vih utiles dans le traitement du sida - Google Patents

Inhibiteurs de la protease du vih utiles dans le traitement du sida

Info

Publication number
EP0912170A4
EP0912170A4 EP97923431A EP97923431A EP0912170A4 EP 0912170 A4 EP0912170 A4 EP 0912170A4 EP 97923431 A EP97923431 A EP 97923431A EP 97923431 A EP97923431 A EP 97923431A EP 0912170 A4 EP0912170 A4 EP 0912170A4
Authority
EP
European Patent Office
Prior art keywords
aids
treatment
protease inhibitors
hiv protease
inhibitors useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97923431A
Other languages
German (de)
English (en)
Other versions
EP0912170A1 (fr
Inventor
Randall W Hungate
Byeong Moon Kim
Joseph P Vacca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613488.7A external-priority patent/GB9613488D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0912170A1 publication Critical patent/EP0912170A1/fr
Publication of EP0912170A4 publication Critical patent/EP0912170A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP97923431A 1996-05-02 1997-04-29 Inhibiteurs de la protease du vih utiles dans le traitement du sida Withdrawn EP0912170A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1668596P 1996-05-02 1996-05-02
US16685P 1996-05-02
GBGB9613488.7A GB9613488D0 (en) 1996-06-27 1996-06-27 HIV protease inhibitors useful in the treatment of aids
GB9613488 1996-06-27
PCT/US1997/006595 WO1997040825A1 (fr) 1996-05-02 1997-04-29 Inhibiteurs de la protease du vih utiles dans le traitement du sida

Publications (2)

Publication Number Publication Date
EP0912170A1 EP0912170A1 (fr) 1999-05-06
EP0912170A4 true EP0912170A4 (fr) 2003-04-09

Family

ID=26309580

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97923431A Withdrawn EP0912170A4 (fr) 1996-05-02 1997-04-29 Inhibiteurs de la protease du vih utiles dans le traitement du sida

Country Status (5)

Country Link
EP (1) EP0912170A4 (fr)
JP (1) JP2000509389A (fr)
AU (1) AU711713B2 (fr)
CA (1) CA2252918A1 (fr)
WO (1) WO1997040825A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007023254A (ja) * 2005-06-14 2007-02-01 Fujifilm Corp 硬化促進剤、熱硬化性樹脂組成物、感光性組成物及び感光性フィルム、並びに、永久パターン及びその形成方法
EP2640699B1 (fr) * 2010-11-17 2015-10-07 Actelion Pharmaceuticals Ltd. Dérivés d'esters de spiro[2.4]heptane pontés
EP2726108B1 (fr) 2011-06-29 2018-01-10 The Trustees of Columbia University in the City of New York Inhibiteur de la connectivité neuronale lié à la susceptibilité à la schizophrénie et à un dysfonctionnement cognitif
AU2015259403B2 (en) 2014-05-13 2017-07-27 Novartis Ag Compounds and compositions for inducing chondrogenesis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337714A2 (fr) * 1988-04-12 1989-10-18 Merck & Co. Inc. Inhibiteurs de la protéase du HIV pour le traitement du SIDA
EP0550924A1 (fr) * 1991-12-16 1993-07-14 Merck & Co. Inc. Dérivés de 2-pyrrolidinone comme inhibiteurs de la HIV protéase
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337714A2 (fr) * 1988-04-12 1989-10-18 Merck & Co. Inc. Inhibiteurs de la protéase du HIV pour le traitement du SIDA
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
EP0550924A1 (fr) * 1991-12-16 1993-07-14 Merck & Co. Inc. Dérivés de 2-pyrrolidinone comme inhibiteurs de la HIV protéase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9740825A1 *

Also Published As

Publication number Publication date
AU2923897A (en) 1997-11-19
EP0912170A1 (fr) 1999-05-06
WO1997040825A1 (fr) 1997-11-06
CA2252918A1 (fr) 1997-11-06
AU711713B2 (en) 1999-10-21
JP2000509389A (ja) 2000-07-25

Similar Documents

Publication Publication Date Title
HU9503170D0 (en) Hiv protease inhibitors useful for the treatment of aids
EP0604182A3 (fr) Inhibiteurs de la protéase du VIH.
EP0434365A3 (en) Hiv protease inhibitors useful for the treatment of aids
AU4019289A (en) Hiv protease inhibitors useful for the treatment of aids
IL102428A0 (en) Inhibitors of hiv protease useful for the treatment of aids
AP9701054A0 (en) Inhibitors of cycteine protease
PL328665A1 (en) Inhibitors of serinic protease
IL108098A0 (en) Inhibitors of hiv protease useful for the treatment of aids
IL105973A0 (en) Inhibitors of hiv protease useful for the treatment of aids
AU1556497A (en) Agents for the treatment and prevention of aids
ZA925023B (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU1697197A (en) Immunoconjugate for the treatment of aids
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
AUPM982594A0 (en) HIV protease inhibitors
IL138127A (en) Process for the synthesis of hiv protease inhibitors
EP0912170A4 (fr) Inhibiteurs de la protease du vih utiles dans le traitement du sida
EP0914125A4 (fr) Inhibiteurs de la protease du vih utilises dans le traitement du sida
GB9508300D0 (en) HIV protease inhibtors for the treatment of aids
GB9613487D0 (en) HIV protease inhibitors useful for the treatment of aids
GB9609663D0 (en) HIV Protease inhibitors useful for the treatment of aids
GB9622443D0 (en) HIV protease inhibitors useful for the treatment of aids
GB9613488D0 (en) HIV protease inhibitors useful in the treatment of aids
ZA939475B (en) Inhibitors of HIV protease useful for the treatment of Aids
ZA928563B (en) HIV protease inhibitors useful for the treatment of AIDS.
ZA9010125B (en) Hiv protease inhibitors useful for the treatment of aids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981202

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030224

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 405/06 B

Ipc: 7C 07D 303/36 B

Ipc: 7C 07D 207/26 B

Ipc: 7C 07C 311/18 B

Ipc: 7C 07C 233/66 B

Ipc: 7C 07D 295/18 B

Ipc: 7C 07D 307/93 B

Ipc: 7C 07C 309/26 B

Ipc: 7C 07C 233/00 B

Ipc: 7C 07D 413/00 B

Ipc: 7C 07D 307/77 B

Ipc: 7C 07D 241/04 B

Ipc: 7A 61K 31/535 B

Ipc: 7A 61K 31/495 B

Ipc: 7A 61K 31/34 B

Ipc: 7A 61K 31/16 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021101